Stelara® (ustekinumab) prescribing information and adverse event reporting is available at www.janssen-pi.co.uk/en/product-information/19
Looking to discover more about Stelara® in the management of inflammatory bowel disease? Our e-learning modules offer a quick, interactive way to get up to speed with the clinical trial results and real-world evidence.
This promotional resource is developed and funded by Janssen and is intended for UK healthcare professionals only.
CP-164684 | July 2021